ArticleACS omega2024
Investigating the Reactive Reinforcement Ability of Maleic Anhydride-Modified Cellulose Nanocrystals via In-Situ Emulsion Polymerization.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
CNC-based nanocomposites have gained substantial interest because of their enhanced thermomechanical properties for high-end engineering applications. The chemical modification of CNCs expands their applicability, making them suitable for use in hydrophobic polymer matrices. The current study investigates the reactive reinforcing ability of maleic anhydride-modified cellulose nanocrystals during the in situ polymerization of a vinyl monomer, i.e., styrene. Highly crystalline nanocellulose (CNCBG) was isolated from
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.